For each study, reviewers extracted data that were deemed to potentially impact efficacy outcomes, such as study population (percent women, mean age, mean duration of OA), study design (duration, washout period, flare requirement, concomitant analgesic use, en- riched enrollment, missing imputation technique), and outcomes (WOMAC score at baseline, endpoint, and change from baseline with measures of variance).